CANMAB 50MG INJECTION contains Trastuzumab which belongs to the group of medicines called Anticancer drugs. It is used to manage breast cancer and stomach cancer. It can be used either alone or in combination with other anticancer drugs (such as paclitaxel, cisplatin, docetaxel, 5-fluorouracil, capecitabine) or hormonal drugs (such as tamoxifen, anastrozole) to achieve better results.
CANMAB 50MG INJECTION will be administered to you only by an oncologist or by a trained professional into your vein or beneath the skin. It is suitable for use in patients with high levels of human epidermal growth factor 2 (HER2) or hormone receptor positive metastatic breast cancer (cancer this is more sensitive for hormonal changes).
Before receiving CANMAB 50MG INJECTION inform your doctor if you have any heart problems (such as heart attack, heart valve disease, or abnormal heartbeat). You must also inform your doctor if you have hypertension as a precaution.
CANMAB 50MG INJECTION is not recommended for use in patients with breathing difficulties. It is also not suitable for use in pregnant or breastfeeding women. Both men and women receiving CANMAB 50MG INJECTION must use a suitable contraceptive method to avoid pregnancy while undergoing therapy with CANMAB 50MG INJECTION.
The most common side effects of receiving this medicine are increased infections, sore throat, mouth ulcers, skin rashes, nausea, stomach upset, lack of sleep, weight loss, tingling and numbness of hands and feet, muscle pain, joint pain, hair loss, shakiness and increased sweating. Consult your doctor if any of these side effect worsens.
No content available
